Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 06, 2023, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 06, 2023, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial".